Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets EXMKT - Delayed Quote USD

CaliPharms, Inc. (KGET)

Compare
0.0000
0.0000
(0.00%)
At close: April 8 at 4:00:00 PM EDT
Loading Chart for KGET
  • Previous Close 0.0000
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.0001
  • Volume 680
  • Avg. Volume 488,984
  • Market Cap (intraday) 10,032
  • Beta (5Y Monthly) -64.08
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

CaliPharms, Inc. engages in the medicinal Cannabis Industry in the United States. It focuses on the THC and CBD beverage industry. The company was formerly known as Kleangas Energy Technologies, Inc. and changed its name to CaliPharms, Inc. in January, 2017. CaliPharms, Inc. is based in Temecula, California.

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: KGET

View More

Performance Overview: KGET

Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

KGET
0.00%
S&P 500 (^GSPC)
7.22%

1-Year Return

KGET
0.00%
S&P 500 (^GSPC)
4.74%

3-Year Return

KGET
0.00%
S&P 500 (^GSPC)
21.58%

5-Year Return

KGET
99.00%
S&P 500 (^GSPC)
95.60%

Compare To: KGET

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: KGET

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    112.47k

  • Net Income Avi to Common (ttm)

    -6.31M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    17.16k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: KGET

View More

Company Insights: KGET

Research Reports: KGET

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.